Part 2 of interview w/ Access Pharmaceuticals C.E.O. Jeffery B. Davis
Here is part 2 of the interview with Access Pharmaceuticals Jeffery B. Davis where he talks about development of Cobalamin, ProLindac, & Thiarabine, and how they all will be of great importance to the future of healthcare.
No comments:
Post a Comment